Inspira surges on accuracy advancements for its blood sensor

Qtrex Quantum

26/12/2023 15:08

** U.S.-listed shares of Israel-based medical device maker
Inspira Technologies  IINN.O  rise 70.8% at $2.03, set to be its
highest in more than a year
    ** Co says its HYLA Blood Sensor achieved 95% accuracy
compared to standard blood gas analyzers
    ** The sensor is used to measure levels of oxygen and carbon
dioxide pressures in blood in a non-invasive manner
    ** Says it will submit a marketing application in the second
half of 2024 for the sensor
    ** Up to last close, stock up 80.6% YTD
    
    

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))